Stocktoria
Canopy Growth Corp CGC
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2010-06-04
Canopy Growth Corp financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $346.8M | $314.0M | $343.9M | $381.2M | $537.6M |
| Gross profit | $69.7M | $79.5M | $80.9M | -$63.5M | -$187.4M |
| R&D expense | $2.6M | $2.7M | $4.6M | $21.7M | $32.3M |
| SG&A expense | $160.0M | $169.6M | $229.4M | $342.5M | $415.4M |
| Operating income | -$161.7M | -$117.1M | -$228.7M | -$2.6B | -$1.0B |
| Interest expense | $38.2M | $74.6M | $105.4M | $126.2M | $103.9M |
| Income tax | $23,000 | $7.1M | $12.3M | -$5.7M | -$8.9M |
| Net income | -$262.9M | -$508.9M | -$693.7M | -$3.3B | -$310.0M |
| EPS (diluted) | $-0.88 | $-4.73 | $-9.27 | $-70.69 | $-7.92 |
| Operating cash flow | -$63.8M | -$165.8M | -$281.9M | -$557.5M | -$545.8M |
| Free cash flow | -$69.1M | -$176.6M | -$285.4M | -$566.7M | -$582.5M |
| Cash & equivalents | $364.7M | $113.8M | $170.3M | $667.7M | $776.0M |
| Inventory | $110.5M | $96.4M | $77.3M | $83.2M | $204.5M |
| Total assets | $1.1B | $917.7M | $1.3B | $2.4B | $5.6B |
| Total liabilities | $421.1M | $439.1M | $899.8M | $1.7B | $2.0B |
| Shareholders' equity | $697.6M | $478.6M | $400.6M | $760.0M | $3.6B |
Source: SEC EDGAR filings · CIK 0001737927 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.